Sign In
Buy ALT
$2.92
+0.0500 (+1.74%)
At Close: Jun 04, 2026
ALT5 joins the Securities Industry and Financial Markets Association (SIFMA) LAS VEGAS, NV / ACCESS Newswire / April 10, 2025 / ALT5 Sigma Corporation (NASDAQ:ALTS)(FRA:5AR1), a fintech specializing i
ALT5 Achieves Record-Breaking Q4 with $5.4 Million in Revenue Customer Base Surpasses 1,000 Accounts, a Historic Milestone Strong Annual Gross Margin of 50.2% and Impressive 18.2% Adjusted EBITDA¹ fo
ALT5 Achieves Record-Breaking Q4 with $5.4 Million in Revenue Customer Base Surpasses 1,000 Accounts, a Historic Milestone Strong Annual Gross Margin of 50.2% and Impressive 18.2% Adjusted EBITDA¹ fo
ALT5 Sigma to Exhibit at Transact Las Vegas April 2-4, 2025
09:00am, Wednesday, 26'th Mar 2025
LAS VEGAS, NV / ACCESS Newswire / March 26, 2025 / ALT5 Sigma Corporation (NASDAQ:ALTS), a fintech, providing next generation blockchain-powered technologies for tokenization, trading, clearing, settl
Buying These Dirt-Cheap Stocks Could Be a Brilliant Move
06:44am, Saturday, 22'nd Mar 2025
Valuation always matters in investing. And sometimes you can find stocks that are especially great bargains.
Altimmune: Pemvidutide Differentiation Advancement In MASH Space Continues To Shine
03:21pm, Monday, 17'th Mar 2025
Altimmune, Inc.'s top-line data from the phase 2b IMPACT study using pemvidutide for the treatment of patients with MASH expected in Q2 of 2025. The global non-alcoholic steatohepatitis [NASH] market
Altimmune to test obesity drug for alcohol use disorder and related health conditions
05:26pm, Thursday, 13'th Mar 2025
Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat alcohol use disorder and alcohol-associated liver disease.
Altimmune to Host Virtual R&D Day on March 13, 2025
07:30am, Thursday, 06'th Mar 2025
Program to Feature Presentations from Renowned KOLs in Obesity, MASH and Two Additional Indications for Pemvidutide following recent IND Clearances by FDA Program to Feature Presentations from Renowne
Altimmune to Participate in the Leerink Global Healthcare Conference
07:30am, Monday, 03'rd Mar 2025
GAITHERSBURG, Md., March 03, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company, today announced that members of the Company's management team will
Altimmune Q4 Earnings Review: The Big News Is The MASH With Obesity Data Readout Due Q2
02:15pm, Friday, 28'th Feb 2025
Altimmune's pemvidutide shows promise in treating MASH with obesity, potentially positioning it as a first-in-class drug targeting both liver health and weight loss. Despite past volatility, ALT stock
Altimmune, Inc. (ALT) Q4 2024 Earnings Call Transcript
02:24pm, Thursday, 27'th Feb 2025
Altimmune, Inc. (NASDAQ:ALT ) Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ET Company Participants Lee Roth - President, Burns McClellan, Investor Relations Advisors Vipin Garg - Chief E
Altimmune Announces Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update
07:00am, Thursday, 27'th Feb 2025
Top-line data from Phase 2b IMPACT trial of pemvidutide in metabolic dysfunction-associated steatohepatitis (MASH) to be reported in Q2 2025 Investigational New Drug (IND) applications in two addition
ALT5 Sigma Wins Best Payment Provider Award at SiGMA Eurasia 2025
02:00pm, Wednesday, 26'th Feb 2025
ALT5 Sigma honored for delivering enterprise-grade crypto payment solutions that enhance security, compliance, and transaction efficiency LAS VEGAS, NEVADA / ACCESS Newswire / February 26, 2025 / ALT5
Seasoned Biopharmaceutical Industry Executives Teri Lawver and Jerry Durso Appointed to Altimmune Board of Directors
07:30am, Tuesday, 25'th Feb 2025
Ms. Lawver, former Chief Commercial Officer of Dexcom and Global Vice President at Johnson & Johnson responsible for billion-dollar Immunology and Cardiovascular & Metabolism Portfolios over her 20-ye
Old Glory Bank and ALT 5 Sigma Expand Crypto Payment Options for Reg A+ Offering
08:30am, Thursday, 20'th Feb 2025
Now Accepting $TRUMP Coin, Along with Bitcoin, Ethereum, Bitcoin Cash, Dogecoin, Litecoin, and More LAS VEGAS, NV / ACCESS Newswire / February 20, 2025 / Old Glory Bank, a pro-America financial instit
